Counterfeit weight-loss jabs are booming – and doctors are worried

The proliferation of counterfeit weight-loss injections is generating significant alarm among medical professionals globally. These unauthorized versions, often referred to as “dupes,” primarily involve the experimental compound retatrutide, which is currently undergoing clinical trials for its potential in weight management. A key concern is that retatrutide has not yet received official approval from regulatory authorities, meaning its safety and efficacy for public use have not been established or guaranteed by oversight bodies. Despite this crucial lack of regulatory clearance, the black market is seeing a substantial increase in the availability and sale of these unverified products. Doctors are deeply worried about the potential health risks to individuals who obtain and use these unapproved substances. These risks include exposure to unknown ingredients, contaminants, incorrect dosages, and the absence of the actual therapeutic compound, all of which can lead to unpredictable and potentially severe adverse health consequences for users. The unregulated nature of these products bypasses all standard safety protocols, posing a serious public health threat.